Pivotal announced today that it has been contracted by Checkpoint Therapeutics Inc., a New York City-based biotechnology company, to provide expert clinical research services in Europe for its upco...
Read moreSpanish investigators from the IDIBAPS-Hospital Clínic of Barcelona have led an international effort to develop an epigenetic clock that is able to trace the past proliferative history of cancer cell...
Read moreOncoheroes today announced its organizational membership into the Coalition Against Childhood Cancer, known as CAC2, a collaborative network of organizations and individuals supporting and servicing t...
Read moreLa compañía especializada en medicina de precisión para el tratamiento y diagnóstico del cáncerOncoDNAha organizado el taller formativo online Oncología de Precisión: De la básica molecular a ...
Read moreEl cáncer de páncreas afecta mayoritariamente a personas de entre 65 y 70 años y es un tumor de difícil diagnóstico y una alta mortalidad.
Read moreFlomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) operating in the genomics and liquid biopsy fields is excited to announce the launch of its seed investment round of 500.0...
Read moreA process system for the pharmaceutical company Boryung Pharmaceutical in Yesan led by Telstar under a contract holder agreement.
Read moreUn estudio dirigido por la Dra. Beatríz González Astorga, investigadora del grupo A01-TECNOLOGIA APLICADA A ONCOLOGIA Y TERAPIA GENICA del ibs.GRANADA en el Hospital Universitario Clínico San Ceci...
Read moreAtrys Health (BME:ATRY), compañía española que brinda servicios de diagnóstico y tratamiento médico de precisión y pionera en los ámbitos de la telemedicina y de la radioterapia de última gene...
Read moreScientist Cristina Mayor-Ruiz joins the Institute for Research in Biomedicine (IRB Barcelona) to lead the new Targeted Protein Degradation and Drug Discovery Lab. Along with the addition of this group...
Read moreYsios Capital, a leading Spanish biotechnology venture capital firm, today announced that its portfolio company Galecto Inc. has priced its initial public offering (IPO) and is trading on the Nasdaq G...
Read moreInvestigadores españoles han descrito nuevos mecanismos moleculares implicados en la visión binocular, es decir, cuando los dos ojos se utilizan conjuntamente. El trabajo, realizado en ratones y pub...
Read more